Collectively, these findings demonstrate, contrary to the goal of the intervention, that ICI therapy reduces the number of T cells infiltrating ccRCC tumours and highlight that in comparison to normal kidney tissue that ccRCCs are highly infiltrated by different types of myeloid lineage cells, with ICI inducing a moderate increase in CD68+ myeloid lineage cells. The gene discussed is CD68; the disease is neoplasm.